HIF1α/HIF2α–Sox2/Klf4 signaling occurs in hypoxic regions of GBM and promotes malignant progression via positive feedback of the EGFR–PI3K/AKT signaling pathway. The gene discussed is EGFR; the disease is glioblastoma.